Back to Results
First PageMeta Content
Coagulation / Octapharma / Factor X / Thrombogenicity / Thrombin / Coagulation system / Blood / Anatomy


PUBLIC WORKSHOP: RISK MITIGATION STRATEGIES TO ADDRESS PROCOAGULANT ACTIVITY IN IMMUNE GLOBULIN PRODUCTS
Add to Reading List

Open Document

File Size: 226,69 KB

Share Result on Facebook

City

Vienna / Rockville / /

/

Facility

Austria MARIETTA PUTZ Octapharma SAULIUS BUTENAS University of Vermont / /

IndustryTerm

manufacturing process validation / medicinal products / manufacturing process / /

MedicalCondition

thrombosis / /

Organization

DOROTHY SCOTT Center / office of Blood Research / University of Vermont / European Union / DEPARTMENT OF HEALTH AND HUMAN SERVICES / CBER JOHANNES DODT Paul-Ehrlich-Institut PETER L. TURECEK / Paul-Ehrlich-Institut / U.S. Food and Drug Administration / Vanderbilt University / /

Person

JOHANNES DODT / Rhonda Dawson / Jean-Hugues Trouvin / PETER L. TURECEK / ELAINE GRAY NIBSC JUAN JORQUERA / Baxter BioScience / JEAN-HUGUES TROUVIN AFSSAPS JAY EPSTEIN / /

Position

Governor / Director / /

ProvinceOrState

Maryland / Vermont / /

SocialTag